Cargando…
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
Autores principales: | Shulman, David S., Klega, Kelly, Imamovic-Tuco, Alma, Clapp, Andrea, Nag, Anwesha, Thorner, Aaron R., Van Allen, Eliezer, Ha, Gavin, Lessnick, Stephen L., Gorlick, Richard, Janeway, Katherine A., Leavey, Patrick J., Mascarenhas, Leo, London, Wendy B., Vo, Kieuhoa T., Stegmaier, Kimberly, Hall, David, Krailo, Mark D., Barkauskas, Donald A., DuBois, Steven G., Crompton, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474275/ https://www.ncbi.nlm.nih.gov/pubmed/30880335 http://dx.doi.org/10.1038/s41416-019-0424-7 |
Ejemplares similares
-
Detection of circulating tumour DNA is associated with
inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s
Oncology Group
por: Shulman, David S., et al.
Publicado: (2018) -
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2022) -
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma
por: Shulman, David S., et al.
Publicado: (2023) -
Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019) -
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
por: Shulman, David S., et al.
Publicado: (2022)